Albuquerque, NM, United States of America

Jerilyn A Timlin


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jerilyn A. Timlin: Innovator in Pathogen Detection and Imaging Technologies

Introduction

Jerilyn A. Timlin is a prominent inventor based in Albuquerque, NM (US). She has made significant contributions to the fields of pathogen detection and imaging technologies. With a total of 2 patents, her work focuses on advancing methods for identifying pathogens and enhancing imaging techniques.

Latest Patents

Timlin's latest patents include "Rapid culture free pathogen detection via spectrally resolved fluorescence microscopy" and "Hyperspectral stimulated emission depletion microscopy and methods of use thereof." The first patent describes methods that utilize optical spectroscopy techniques to identify and characterize pathogens in a sample. This is achieved through the detection of unique properties and analytes specific to particular pathogens. The second patent presents a hyperspectral stimulated emission depletion (STED) microscope system designed for high-resolution imaging of samples labeled with multiple fluorophores. This innovative microscope includes a light source and optical systems for generating and focusing excitation and depletion light beams on a sample, allowing for multi-color, sub-diffraction imaging.

Career Highlights

Throughout her career, Jerilyn has worked with notable organizations such as Sandia Corporation and UNM Rainforest Innovations. Her experience in these institutions has allowed her to develop and refine her innovative technologies.

Collaborations

Some of her coworkers include Jesse S. Aaron and Aaron Neumann, who have collaborated with her on various projects.

Conclusion

Jerilyn A. Timlin's contributions to pathogen detection and imaging technologies highlight her role as a leading innovator in her field. Her patents reflect her commitment to advancing scientific knowledge and improving diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…